Gastrointestinal symptoms - an illness burden that affects daily work in patients with IBS.
Confidence in public health
Disease burden
IBS
Sense of coherence
Journal
Health and quality of life outcomes
ISSN: 1477-7525
Titre abrégé: Health Qual Life Outcomes
Pays: England
ID NLM: 101153626
Informations de publication
Date de publication:
01 Jul 2019
01 Jul 2019
Historique:
received:
02
08
2017
accepted:
06
06
2019
entrez:
3
7
2019
pubmed:
3
7
2019
medline:
21
8
2019
Statut:
epublish
Résumé
Irritable Bowel Syndrome (IBS) is a chronic gastrointestinal disorder characterised by recurrent abdominal pain and disturbed bowel habits and unclear aetiology. IBS is also associated with psychosocial factors, impaired quality of life and lost work productivity. This study sought to determine whether the association between IBS and lost work productivity might be accounted for by poor coping strategies and loss of confidence in the healthcare system. Case-control design was employed sampling IBS and non-gastrointestinal (non-GI) primary healthcare seekers in a defined region in Sweden. Non-GI patients were of similar age and sex distribution to the IBS patients. Questionnaires applied in this study included instruments designed to measure confidence in the social security system and in the community, as well as questions about whether gastrointestinal problems might affect working life and Sense of coherence (SOC) questionnaire. The study's primary hypothesis was evaluated via an a priori path model. Statistically significant differences were found between IBS cases (n = 305) and controls (n = 369) concerning abdominal pain or discomfort affecting everyday performance at work (p < 0.0001). IBS cases also showed significantly lower (p = 0.001) confidence in public healthcare. The study's hypothesis was supported with the finding of a statistically significant indirect association via poor coping strategies, although the indirect associations were lesser in magnitude than the direct association. This study found a clear association between clinically diagnosed IBS status and interference in work by gastrointestinal symptoms in which sense of coherence might be of importance.
Sections du résumé
BACKGROUND
BACKGROUND
Irritable Bowel Syndrome (IBS) is a chronic gastrointestinal disorder characterised by recurrent abdominal pain and disturbed bowel habits and unclear aetiology. IBS is also associated with psychosocial factors, impaired quality of life and lost work productivity. This study sought to determine whether the association between IBS and lost work productivity might be accounted for by poor coping strategies and loss of confidence in the healthcare system.
METHODS
METHODS
Case-control design was employed sampling IBS and non-gastrointestinal (non-GI) primary healthcare seekers in a defined region in Sweden. Non-GI patients were of similar age and sex distribution to the IBS patients. Questionnaires applied in this study included instruments designed to measure confidence in the social security system and in the community, as well as questions about whether gastrointestinal problems might affect working life and Sense of coherence (SOC) questionnaire. The study's primary hypothesis was evaluated via an a priori path model.
RESULTS
RESULTS
Statistically significant differences were found between IBS cases (n = 305) and controls (n = 369) concerning abdominal pain or discomfort affecting everyday performance at work (p < 0.0001). IBS cases also showed significantly lower (p = 0.001) confidence in public healthcare. The study's hypothesis was supported with the finding of a statistically significant indirect association via poor coping strategies, although the indirect associations were lesser in magnitude than the direct association.
CONCLUSIONS
CONCLUSIONS
This study found a clear association between clinically diagnosed IBS status and interference in work by gastrointestinal symptoms in which sense of coherence might be of importance.
Identifiants
pubmed: 31262316
doi: 10.1186/s12955-019-1174-1
pii: 10.1186/s12955-019-1174-1
pmc: PMC6604450
doi:
Types de publication
Journal Article
Langues
eng
Pagination
113Références
Psychosom Med. 1999 Mar-Apr;61(2):148-53
pubmed: 10204966
Scand J Gastroenterol. 1999 Mar;34(3):259-63
pubmed: 10232869
Gut. 2000 Jan;46(1):78-82
pubmed: 10601059
Psychosom Med. 2000 May-Jun;62(3):309-17
pubmed: 10845344
Child Abuse Negl. 2000 Jun;24(6):799-810
pubmed: 10888019
Eur J Gastroenterol Hepatol. 2001 Nov;13(11):1327-32
pubmed: 11692059
Aliment Pharmacol Ther. 2002 Jun;16(6):1171-85
pubmed: 12030961
Dig Liver Dis. 2003 Apr;35(4):256-61
pubmed: 12801037
Am J Epidemiol. 1992 Jul 15;136(2):165-77
pubmed: 1415139
Scand J Caring Sci. 1992;6(3):165-71
pubmed: 1439378
Nurs Res. 2003 Sep-Oct;52(5):329-37
pubmed: 14501547
Gen Hosp Psychiatry. 2004 Jan-Feb;26(1):50-8
pubmed: 14757303
Scand J Public Health. 2003;31(4):297-304
pubmed: 15099036
Am J Gastroenterol. 2005 May;100(5):1174-84
pubmed: 15842596
Gastroenterol Clin North Am. 2005 Jun;34(2):173-87
pubmed: 15862928
Am J Manag Care. 2005 Apr;11(1 Suppl):S17-26
pubmed: 15926760
Eur J Gen Pract. 2006;12(2):88-90
pubmed: 16945886
Am J Gastroenterol. 2007 Feb;102(2):371-9
pubmed: 17156145
Gut. 2007 Dec;56(12):1770-98
pubmed: 17488783
Curr Gastroenterol Rep. 2009 Aug;11(4):265-9
pubmed: 19615301
Rehabil Psychol. 2009 Feb;54(1):99-108
pubmed: 19618709
Brain Behav Immun. 2011 Mar;25(3):386-94
pubmed: 21094682
J Neurogastroenterol Motil. 2011 Apr;17(2):131-9
pubmed: 21602989
Nat Rev Neurosci. 2011 Jul 13;12(8):453-66
pubmed: 21750565
Curr Med Res Opin. 2011 Nov;27(11):2213-22
pubmed: 21951105
Int J Health Geogr. 2012 Feb 06;11:5
pubmed: 22309613
Am J Physiol Gastrointest Liver Physiol. 2012 May 15;302(10):G1085-98
pubmed: 22403791
Am J Physiol Gastrointest Liver Physiol. 2012 May 15;302(10):G1075-84
pubmed: 22403795
Am J Physiol Gastrointest Liver Physiol. 2012 Oct;303(7):G775-85
pubmed: 22837345
N Engl J Med. 2012 Oct 25;367(17):1626-35
pubmed: 23094724
J Psychosom Res. 2013 Nov;75(5):467-74
pubmed: 24182637
World J Gastroenterol. 2014 Mar 14;20(10):2456-69
pubmed: 24627583
BMC Fam Pract. 2015 Jan 28;16:6
pubmed: 25626450
Nat Rev Gastroenterol Hepatol. 2015 Oct;12(10):592-605
pubmed: 26303675
Neurogastroenterol Motil. 2017 Jan;29(1):null
pubmed: 27401139
Neurogastroenterol Motil. 2017 Feb;29(2):
pubmed: 27581702
Gastroenterology. 1995 Sep;109(3):671-80
pubmed: 7657095
Science. 1977 Apr 8;196(4286):129-36
pubmed: 847460
Eur J Gastroenterol Hepatol. 1997 Apr;9(4):345-52
pubmed: 9160196
Aliment Pharmacol Ther. 1997 Jun;11(3):553-9
pubmed: 9218082
Fam Med. 1997 Sep;29(8):568-71
pubmed: 9310755
Psychosom Med. 1998 May-Jun;60(3):258-67
pubmed: 9625212